A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.

U Lassen; M Sorensen; PB Jensen; SW Langer; BB Jensen; N Jeppesen; C Rytter; A Mellemgaard; O Hansen; K Osterlind

A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.

U Lassen, M Sorensen, PB Jensen, SW Langer, BB Jensen, N Jeppesen, C Rytter, A Mellemgaard, O Hansen, K Osterlind

Research output: Contribution to journal › Conference article › Research › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	22
Issue number	14
Pages (from-to)	667S-667S
Number of pages	1
ISSN	0732-183X
Publication status	Published - 15 Jul 2004
Event	40th Annual Meeting of the American-Society-of-Clinical-Oncology - New Orleans, Lao People's Democratic Republic Duration: 5 Jun 2004 → 8 Jun 2004

Conference

Conference	40th Annual Meeting of the American-Society-of-Clinical-Oncology
Country/Territory	Lao People's Democratic Republic
City	New Orleans
Period	05/06/2004 → 08/06/2004

Library access?

Check availability at the Royal Danish Library

Cite this

Lassen, U., Sorensen, M., Jensen, PB., Langer, SW., Jensen, BB., Jeppesen, N., Rytter, C., Mellemgaard, A., Hansen, O., & Osterlind, K. (2004). A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results. Journal of Clinical Oncology, 22(14), 667S-667S.

A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results. / Lassen, U; Sorensen, M; Jensen, PB et al.
In: Journal of Clinical Oncology, Vol. 22, No. 14, 15.07.2004, p. 667S-667S.

Research output: Contribution to journal › Conference article › Research › peer-review

Lassen, U, Sorensen, M, Jensen, PB, Langer, SW, Jensen, BB, Jeppesen, N, Rytter, C, Mellemgaard, A, Hansen, O & Osterlind, K 2004, 'A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.', Journal of Clinical Oncology, vol. 22, no. 14, pp. 667S-667S.

@inproceedings{4327b518a22c46869abc9a97ac52e293,

title = "A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.",

author = "U Lassen and M Sorensen and PB Jensen and SW Langer and BB Jensen and N Jeppesen and C Rytter and A Mellemgaard and O Hansen and K Osterlind",

year = "2004",

month = jul,

day = "15",

language = "English",

volume = "22",

pages = "667S--667S",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "14",

note = "40th Annual Meeting of the American-Society-of-Clinical-Oncology ; Conference date: 05-06-2004 Through 08-06-2004",

}

TY - GEN

T1 - A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease

T2 - 40th Annual Meeting of the American-Society-of-Clinical-Oncology

AU - Lassen, U

AU - Sorensen, M

AU - Jensen, PB

AU - Langer, SW

AU - Jensen, BB

AU - Jeppesen, N

AU - Rytter, C

AU - Mellemgaard, A

AU - Hansen, O

AU - Osterlind, K

PY - 2004/7/15

Y1 - 2004/7/15

M3 - Conference article

SN - 0732-183X

VL - 22

SP - 667S-667S

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

Y2 - 5 June 2004 through 8 June 2004

ER -